期刊文献+

鱼藤酮诱导SH-SY5Y细胞对过氧化氢损伤易感性增高与硫氧还蛋白下调有关(英文) 被引量:1

Increased Susceptibility to H_2O_2 in SH-SY5Y Cells Affected by Rotenone Is Accompanied by the Decrease of Thioredoxin
下载PDF
导出
摘要 帕金森病(PD)的发病机制与线粒体呼吸链复合物I(complex I)活性降低以及氧化应激损伤密切相关.使用complex I特异性抑制物鱼藤酮,损伤人神经母细胞瘤SH-SY5Y细胞后,给予H2O2造成氧化应激损伤,以研究细胞抗氧化损伤能力变化的可能机制.结果表明,鱼藤酮处理后,细胞对H2O2所致氧化损伤的易感性增高,且细胞形态及细胞存活率的改变与鱼藤酮浓度呈量效关系.与此同时,细胞内抗氧化蛋白之一,硫氧还蛋白(thioredoxin)水平在细胞损伤时明显下降.以上结果表明,线粒体complex I抑制对细胞氧化应激易感性的影响可能与胞内硫氧还蛋白水平降低有关,提示硫氧还蛋白在诊断神经元损伤和神经保护中有一定的运用前景. The inhibition of mitochondrial respiratory chain complex I and oxidative damage have been implicated in the pathogenesis of Parkinson's disease (PD). To study the alteration of cellular antioxidant capability with complex I impairment, human neuroblastoma SH-SYSY cells were treated by specific mitochondrial complex I inhibitor rotenone and followed by H2O2 exposure. The susceptibility of complex I inhibition cells to H2O2 was found to be increased in a dose-dependent manner in cell morphology observation and ceil viability detection. Meanwhile, one of antioxidant proteins, thioredoxin, was downregulated following the oxidative stress, which suggests the potential role of thioredoxin as a neuronal injury index as well as a therapeutic target for neuroprotection.
机构地区 南京大学医学院
出处 《南京大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第5期470-478,共9页 Journal of Nanjing University(Natural Science)
关键词 线粒化 氧化应激 鱼藤酮 硫氧还蛋白 帕金森病 rnitochondria, oxidative stress, rotenone, thioredoxin, Parkinson's disease
  • 相关文献

参考文献15

  • 1Greenamyre J T, Sherer T B, Betarbet R, etal.Complex Ⅰ and parkinson's disease. International Union of Biochemistry and Molecular Biology Life, 2001, 52(3-5) :135-141.
  • 2Schapira A H, Cooper J M, Dexter D, etal. Mitochondrail complex Ⅰ deficiency in Parkinson' sdisease. Journal of Neurochemistry, 1990, 54(3):823-827.
  • 3Betarbet R, Sherer T B, MacKenzie G, et al.Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neuroscience, 2000, 3(12).. 1 301-1 306.
  • 4Dexter D T, Carter C J, Wells F R, etal. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry, 1989, 52(2):381-389.
  • 5Zhang J, Perry G, Smith M A, et al. Parkinson's disease is associated with oxidative damageto cytoplasmic DNA and RNA in substantia nigra neurons. The American Journal of Pathology,1999, 154(5): 1 423-1 429.
  • 6Parker W D Jr, Boyson S J, Parks J K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of Neurology,1989, 26(6): 719-723.
  • 7Bai J, Nakamura H, Hattori I, et al. Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neuroscience Letters, 2002, 321(1-2):81-84.
  • 8Sherer T B, Trimmer P A, Borland K, et al.Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Research, 2001, 891(1-2): 94-105.
  • 9Emerit J, Edeas M, Bricaire F. Neurodegerative diseases and oxidative stress. Biomedicine and Pharmacotherapy, 2004, 58(1): 39-46.
  • 10赵蕾,高静.硫氧还蛋白与神经退行性病变[J].生理科学进展,2002,33(1):74-76. 被引量:3

二级参考文献14

  • 1[1]Lovell MA, Xie C, Gabbita SP. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's Disease. Free Radic Bio Med, 2000, 28∶418~427.
  • 2[2]Powis G. Thioredoxin reductase. Biochem J,2000,346∶1~8.
  • 3[3]Yamagata K, Tagamim M. Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci Lett, 2000, 284∶131~134.
  • 4[4]Hirota K,Matsui M. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA, 1997, 94∶3633~3638.
  • 5[5]Saitoh M,Nishitoh H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase(ASK)1. EMBO J, 1998, 17∶2596~2606.
  • 6[6]Yakagi Y, Horikawa F. Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci Lett ,1998, 17∶251∶25~28.
  • 7[7]Takagi Y, Tokime T. Redox control of neuronal damage during brain ischemia after middle cerebral artery ocolusion in the rat. Immunohistochemical and hybridization studies of thioredoxin. J Cereb Blood Flow Metab ,1998, 18∶206~214.
  • 8[8]Tomimoto H, Akiguehi I. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Research, 1993, 625∶1~8.
  • 9[9]Mafsukio K. Elevation of antioxidant potency in the brain of mice by low-dose gamma-ray irradiation and its effect on 1-methy1-4-pheny-1,2,3,6-tetrahydro-pyridine(MPTP)-induced brain damage. Free Radic Bio Med ,1999, 26∶388~395.
  • 10[10]Takagi Y, Hattori I. Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J Cereb Blood Flow Metab, 2000, 20∶829~833

共引文献5

同被引文献19

  • 1刘延英,赵焕英,赵春礼,段春礼,鲁玲玲,杨慧.SH-SY5Y细胞α-突触核蛋白的过表达可部分抵抗鱼藤酮诱导的氧化应激[J].生理学报,2006,58(5):421-428. 被引量:5
  • 2Spillantini M G,Schmidt M L,Virginia M Y L. α-Synuclein in Lewy bodies[J].Nature,1997,(6645):839-840.
  • 3Hatcher J M,Pennell K D,Miller G W. Parkinson's disease and pesticides:A toxicological perspective[J].Trends in Pharmacological Sciences,2008,(06):322-329.doi:10.1016/j.tips.2008.03.007.
  • 4Masliah E,Rockenstein E,Veinbergs I. Dopaminergic loss and inclusion body formation in α-synuclein mice:implications for neurodegenerative disorders[J].Science,2000,(5456):1265.
  • 5Feany M B,Bender W W. A Drosophila model of Parkinson's disease[J].Nature,2000,(6776):394-398.
  • 6Takahashi M,Kanuka H,Fujiwara H. Phosphorylation of[alpha]-synuclein characteristic of synucleinopathy lesions is recapitulated in[alpha]-synuclein transgenic Drosophila[J].Neuroscience Letters,2003,(03):155-158.
  • 7McLean P,Ribich S,IIvman B. Subcellular localization of a-synuclein in primary neuronal cultures:Effect of missense mutations[J].Advances in Research on Neurodegeneration,2000.53.
  • 8Maroteaux L,Campanelli J,Scheller R. Synuclein:A neuron-specific protein localized to the nucleus and presynaptic nerve terminal[J].Journal of Neuroscience,1988,(08):2804.
  • 9Cookson M R. The biochemistry of Parkinson's disease[J].Annual Review of Biochemistry,2005.29-52.
  • 10Kontopoulos E,Parvin J D,Feany M B. alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity[J].Human Molecular Genetics,2006,(20):3012-3023.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部